| Aug 6 |
Emergent Biosolutions: Q2 Earnings Snapshot
|
| Aug 6 |
Emergent BioSolutions Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 6 |
Emergent BioSolutions Reports Second Quarter 2024 Financial Results
|
| Aug 6 |
Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the Country
|
| Aug 5 |
Emergent Biosolutions Q2 2024 Earnings Preview
|
| Aug 2 |
Emergent BioSolutions (NYSE:EBS shareholders incur further losses as stock declines 23% this week, taking three-year losses to 83%
|
| Jul 31 |
Emergent Bio gains as RSDL sale nets $75M
|
| Jul 31 |
Emergent BioSolutions Completes Sale of RSDL® (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 Million
|
| Jul 25 |
The stock market’s cruel summer is about to get much worse
|
| Jul 24 |
Emergent BioSolutions Launches Opioid Emergency Preparedness ‘Lay, Spray, Stay’ Public Education Campaign Starring Pro Football Hall of Famer Emmitt Smith
|
